Horizon Investments’s United Therapeutics UTHR Stock Holding History

Horizon Investments’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.7M	Sell	23,364 -1,038	-4%	-$585K	0.14%	119
2026 Q1	$14.5M	Sell	24,402 -2,980	-11%	-$1.48M	0.16%	106
2025 Q4	$13.3M	Buy	27,382 +6,037	+28%	+$2.81M	0.17%	102
2025 Q3	$8.95M	Buy	21,345 +3,962	+23%	+$1.33M	0.12%	141
2025 Q2	$5M	Buy	17,383 +17,373	+173,730%	+$5.19M	0.08%	195
2025 Q1	$3.08K	Hold	10	–	–	﹤0.01%	702
2024 Q4	$3.53K	Hold	10	–	–	﹤0.01%	695
2024 Q3	$3.58K	Buy	10 +3	+43%	+$1.01K	﹤0.01%	675
2024 Q2	$2.23K	Hold	7	–	–	﹤0.01%	681
2024 Q1	$1.61K	Buy	7 +4	+133%	+$903	﹤0.01%	687
2023 Q4	$660	Buy	3 +1	+50%	+$230	﹤0.01%	695
2023 Q3	$452	Hold	2	–	–	﹤0.01%	723
2023 Q2	$442	Hold	2	–	–	﹤0.01%	693
2023 Q1	$448	Buy	+2	New	+$493	﹤0.01%	695

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Horizon Investments's UTHR Position: Q2 2026 in Review

Horizon Investments reduced its United Therapeutics (UTHR) stake by 4.3% in Q2 2026, selling an estimated $585K and leaving 23,364 shares worth $12.7M. The position accounts for 0.14% of the portfolio, ranked #119.

Horizon Investments first reported a position in UTHR in Q1 2023 and has held it in 14 quarters since. The position peaked at $14.5M in Q1 2026. 874 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Horizon Investments held 23,364 shares of United Therapeutics worth $12.7M as of Q2 2026.
Horizon Investments sold 1,038 United Therapeutics shares in Q2 2026, an estimated $585K.
United Therapeutics made up 0.14% of Horizon Investments's portfolio in Q2 2026, its #119 holding.
Horizon Investments first reported a position in United Therapeutics in Q1 2023 and has held it in 14 quarters since.
Horizon Investments's United Therapeutics position peaked at $14.5M in Q1 2026.
874 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.